Companion Animal Therapeutics


Canine Parvovirus Antibody, Goose Origin (USDA License Pending)

Currently experimental, not available for sale. 


A field study involving 120 candidates conducted at 11 sites has shown parvoONE reduces mortality rate to 12% with an average hospitalization time of 2.8 days, compared to approximately 5-7 days of hospitalization time when only supportive care is given.  In addition to the shortened hospitalization times, very few candidates received IV fluids thus substantially reducing overall costs of treating Parvovirus infections.